Featured Research

from universities, journals, and other organizations

Exposure to common toxic substances could increase asthma symptoms

Date:
August 31, 2012
Source:
European Lung Foundation
Summary:
Children who are exposed to polychlorinated biphenyls (PCBs), which were commonly used in a range of industrial products, could be at risk of an increase in asthma symptoms, according to new research.

Children who are exposed to polychlorinated biphenyls (PCBs), which were commonly used in a range of industrial products, could be at risk of an increase in asthma symptoms, according to new research.

The study will be presented in a poster discussion September 2, 2012 at the European Respiratory Society's Annual Congress in Vienna.

PCBs were regularly used between 1930s and 1970s in a range of electrical equipment, lubricants and paint additives. They were eventually phased out due to the harm they were causing to the environment and animals.

Although they are not widely used now, the toxic substance does not break down easily. It can be transported in water and air and it can exist in the environment, particularly at waste sites, for a number of years.

Researchers from the University of Queensland in Australia examined 240 children to assess the impact PCBs are having on asthma symptoms. They measured the levels of PCBs found in their blood, along with three pesticides, and also assessed prevalence of wheeze, a common symptom of asthma.

The results found that overall, those with higher levels of PCBs were more likely to report wheeze (odds ratio 1.61). The findings also suggest that the link between PCBs and wheeze was stronger in non-atopic (non-allergic) asthma.

Lead author, Professor Sly, from the University of Queensland, said: "Despite PCBs being banned from use in many countries, people are still suffering from the effects of these toxic substances. Our findings suggest that people with high levels of the chemicals in their blood stream are suffering from higher levels of wheeze, a common asthma symptom.

"This could be due to high concentration levels being passed from a mother to a baby while in the womb, or PCBs may be ingested if a person consumes contaminated food. They could also be inhaled from contaminated hazardous waste sites."


Story Source:

The above story is based on materials provided by European Lung Foundation. Note: Materials may be edited for content and length.


Cite This Page:

European Lung Foundation. "Exposure to common toxic substances could increase asthma symptoms." ScienceDaily. ScienceDaily, 31 August 2012. <www.sciencedaily.com/releases/2012/08/120831203414.htm>.
European Lung Foundation. (2012, August 31). Exposure to common toxic substances could increase asthma symptoms. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/08/120831203414.htm
European Lung Foundation. "Exposure to common toxic substances could increase asthma symptoms." ScienceDaily. www.sciencedaily.com/releases/2012/08/120831203414.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins